Language:

Results 1 - 20 of 2,503 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Refined by: Journal Title: Vaccines

Result Number	Material Type	Record Details and Options
1	Material Type: Article	Efforts at COVID-19 Vaccine Development: Challenges and Successes Vaccines (Basel), 2020-12, Vol.8 (4), p.739 [Peer Reviewed Journal] 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8040739 ;PMID: 33291245 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review Vaccines (Basel), 2020-12, Vol.9 (1), p.16 [Peer Reviewed Journal] 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010016 ;PMID: 33396832 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine Vaccines (Basel), 2022-01, Vol.10 (1), p.86 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10010086 ;PMID: 35062747 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Nanomaterial Delivery Systems for mRNA Vaccines Vaccines (Basel), 2021-01, Vol.9 (1), p.65 [Peer Reviewed Journal] 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010065 ;PMID: 33478109 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Vaccines (Basel), 2021-05, Vol.9 (5), p.467 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050467 ;PMID: 34066475 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines Vaccines (Basel), 2021-09, Vol.9 (9), p.1033 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9091033 ;PMID: 34579270 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination Vaccines (Basel), 2021-04, Vol.9 (5), p.435 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050435 ;PMID: 33946748 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19 Vaccines (Basel), 2021-03, Vol.9 (3), p.243 [Peer Reviewed Journal] 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030243 ;PMID: 33799505 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences Vaccines (Basel), 2022-06, Vol.10 (6), p.919 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10060919 ;PMID: 35746526 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Progress and Prospects on Vaccine Development against SARS-CoV-2 Vaccines (Basel), 2020-03, Vol.8 (2), p.153 [Peer Reviewed Journal] 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8020153 ;PMID: 32235387 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis Vaccines (Basel), 2021-09, Vol.9 (10), p.1071 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101071 ;PMID: 34696179 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors Vaccines (Basel), 2022-01, Vol.10 (1), p.110 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10010110 ;PMID: 35062771 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review Vaccines (Basel), 2022-06, Vol.10 (6), p.973 [Peer Reviewed Journal] 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10060973 ;PMID: 35746581 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy Vaccines (Basel), 2021-04, Vol.9 (4), p.378 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9040378 ;PMID: 33924534 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia Vaccines (Basel), 2021-06, Vol.9 (6), p.674 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9060674 ;PMID: 34207394 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects Vaccines (Basel), 2021-05, Vol.9 (6), p.556 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9060556 ;PMID: 34073382 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm Vaccines (Basel), 2021-04, Vol.9 (5), p.436 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050436 ;PMID: 33946736 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	An Update on Self-Amplifying mRNA Vaccine Development Vaccines (Basel), 2021-01, Vol.9 (2), p.97 [Peer Reviewed Journal] 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9020097 ;PMID: 33525396 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland Vaccines (Basel), 2021-03, Vol.9 (3), p.218 [Peer Reviewed Journal] 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030218 ;PMID: 33806641 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers Vaccines (Basel), 2021-09, Vol.9 (10), p.1092 [Peer Reviewed Journal] 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101092 ;PMID: 34696200 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by